Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

References

• Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 2000;32 Suppl 1:48–62.
   Google Scholar
• Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616–20.
   PubMed Web of Science ®Google Scholar
• Haddow JE, Ledue TB. Preventing manifestations of hereditary haemochromatosis through population-based screening. J Med Screen 1994;1:16–21.
   PubMedGoogle Scholar
• Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.
   PubMed Web of Science ®Google Scholar
• Merryweather Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275–8.
   PubMed Web of Science ®Google Scholar
• Bacon BR, Powell LW, Adams PC, Kresina T, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999;116:193–207.
   Google Scholar
• Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994;356:293–302.
   PubMedGoogle Scholar
• Niederau C, Stremmel W, Strohmeyer GW. Clinical spectrum and management of haemochromatosis. Baillieres Clin Haematol 1994;7:881–901.
   PubMedGoogle Scholar
• Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107–19.
   PubMed Web of Science ®Google Scholar
• Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139–200.
   Google Scholar
• Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172–8.
   PubMed Web of Science ®Google Scholar
• Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994;40:1631–6.
   PubMed Web of Science ®Google Scholar
• Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost- effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994;154:769–76.
   Google Scholar
• Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology 1995;109: 177–88.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Ikkala E, Reunanen A, Takkunen H, Vuori E, Makinen J. Prevalence of hemochromatosis in Finland. Acta Med Scand 1988;224:385–90.
   PubMedGoogle Scholar
• Wiggers P, Dalhoj J, Kiaer H, Ring Larsen H, Petersen PH, Blaabjerg O, et al. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991;230:265–70.
   Google Scholar
• Bell H, Thordal C, Raknerud N, Hansen T, Bosnes V, Halvorsen R, et al. Prevalence of hemochromatosis among first-time and repeat blood donors in Norway. J Hepatol 1997;26:272–9.
   PubMed Web of Science ®Google Scholar
• Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 2000;31:1160–4.
   PubMed Web of Science ®Google Scholar
• Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995;98: 464–8.
   Google Scholar
• Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994;107:453–9.
   PubMed Web of Science ®Google Scholar
• Hallberg L, Bjorn Rasmussen E, Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med 1989;225:249–55.
   PubMed Web of Science ®Google Scholar
• Hickman PE, Hourigan LF, Powell LW, Cordingley F, Dimeski G, Ormiston B, et al. Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis. Gut 2000;46: 405–9.
   PubMed Web of Science ®Google Scholar
• Phatak PD, Sham RL, Raubertas RF, Dunnigan K, O’Leary MT, Braggins C, et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 1998;129: 954–61.
   Google Scholar
• Siedel J, Wahlefeld AW, Ziegenhorn J. AACC meeting abstract. Clin Chem 1984;30:975.
   Google Scholar
• DAKO AS. Human serum transferrin. Glostrup: DAKO A/S, 1994.
   Google Scholar
• Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. Edinburgh: Churchill Livingstone; 1987. p. 181–201.
   Google Scholar
• Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 1999;22:325–6.
   PubMed Web of Science ®Google Scholar
• Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York:Wiley; 1980. p. 10–6.
   Google Scholar
• Bland M. An introduction to medical statistics. Oxford: Oxford University Press; 1995.
   Google Scholar
• Holmen J, Midthjell K, Bjartveit K, Hjort PF, Lund-Larsen PG, Moum T, et al. The Nord-Trøndelag health survey 1984–86. Purpose, background and methods. Participation, non-participation and frequency distributions. Verdal, Norway: Samfunns- medisinsk forskningssenter, Statens Institutt for Folkehelse; 1990. p. 67–87.
   Google Scholar
• Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485–504.
   Google Scholar
• Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6:24–9.
   Google Scholar
• Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Maurer M, et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med 1998;128:337–45.
   Google Scholar
• McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer–Strawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999;107:30–7.
   Google Scholar
• Mueller RF, Young ID. Emery’s elements of medical genetics. Edinburgh: Churchill Livingstone; 1998. p. 113–26.
   Google Scholar
• Distante S, Berg JP, Lande K, Haug E, Bell H. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 1999;34: 529–34.
   Google Scholar
• Distante S, Berg JP, Lande K, Haug E, Bell H. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochroma- tosis. Gut 2000;47: 575–9.
   Google Scholar
• Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718–24.
   PubMed Web of Science ®Google Scholar
• Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, et al. The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. Scand J Gastroenterol 2000;35:1301–7.
   Google Scholar
• Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M, et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203–8.
   Google Scholar
• Cogswell ME, McDonnell SM, Khoury MJ, Franks AL, Burke W, Brittenham G. Iron overload, public health, and genetics: evaluating the evidence for hemochromatosis screening. Ann Intern Med 1998;129:971–9.
   PubMed Web of Science ®Google Scholar
• Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162–6.
   PubMed Web of Science ®Google Scholar